Preparation of transdermal drug delivery system of felodipine-metoprolol and its bioavailability in rabbits

Yaoxue Xuebao

Volumn 42, Issue 11, 2007, Pages 1206-1217

  Wang, Wen Gang ^a   Yun, Liu Hong ^a   Wang, Rui ^b   Fu, Gui Ying ^a   Liu, Ze Yuan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Bioavailability; Felodipine; Metoprolol; Pharmacokinetics; Transdermal drug delivery system

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZEPINE DERIVATIVE; CINEOLE; CYCLOHEXANOL DERIVATIVE; FELODIPINE; LAUROCAPRAM; METOPROLOL; PROPANEDIOL DERIVATIVE; TERPENE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; FEMALE; INTRADERMAL DRUG ADMINISTRATION; MALE; RABBIT; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; AZEPINES; BIOLOGICAL AVAILABILITY; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FELODIPINE; FEMALE; MALE; METOPROLOL; MONOTERPENES; PROPYLENE GLYCOLS; RABBITS; SKIN ABSORPTION;

EID: 37549064383     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Haria M, Plosker GL, Markham A. Felodipine/Metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertention [J]. Drugs, 2000,59:141-157.
2. Dahlof B, Jonsson L, Borgholst O, et al. Improved antihypertensive efficiency of the felodipine-metoprolol extended-release tablet compared with each drug alone [J]. Blood Press, 1993,2 Suppl. 1:37-45.
3. Frishman WH, Hainer JW, Suqq J. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the metoprolol succinate-felodipine antihypertension combination trial (M-FACT) [J]. Am J Hypertens, 2006,19:388-395.
4. Todd PA, Faulds D. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders [J]. Drugs, 1992,44:251-277.
5. Plosker GL, Clissold SP. Controlled release metoprolol formulations: a review of their pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and ischaemic heart disease [J]. Drugs, 1992,43:382-414.
6. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery [J]. Nat Rev Drug Discov, 2004,3:115-124.
7. Kim J, Shin SC. Controlled release of atenolol from the ethylene-vinyl acetate matrix [J]. Int J Pharm, 2004,273:23-27.
8. Zheng JM, Xu H, Ding PT. Pasting principle and pasting test of pharmaceutical patch [J]. J Extern Ther TCM, 2005,14:3-5.
9. Wang WG, Yun LH, Wang R, el al. Simultaneous determination of metoprolol tartrate and felodipine in skin diffuse solution by HPLC [J]. Chin Pharm J, 2006,41:143-146.
10. State Pharmacopoeia Committee of the People' s Republic of China. Pharmacopoeia of the People ' s Republic of China [S]. 2005 ed. Part II. Beijing: Chemical Industry Press, 2005. Appendix XE.
11. Yang LL, Yuan YS, Dai XL. Determination of felodipine concentration in human plasma by GC-ECD and study of its pharmacokinetics [J]. Acta Pharm Sin, 1998,33:461-464.
12. Yang GJ, Hu YS, Zheng X, et al. Determination of metoprolol in plasma by gas chromatography and electron-capture detection [J]. Acta Pharm Sin, 1990,25:457-461.
13. Dru JDY, Hsieh JYK, Matuszewski BK, et al. Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection [J]. J Chromatogr B, 1995,666:259-267.
14. Soons PA, Roosemalen MCM, Breimer DD. Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma [J]. J Chromatogr, 1990,528:343-356.
15. Nishioka R, Umeda I, Oi N. Determination of felodipine and its metabolites in plasma using capillary gas chromatography with electron-capture detection and their identification by gas chromatography-mass spectrometry [J]. J Chromatogr, 1991,565:237-246.
16. Yang LL, Tan L, Yuan YS. Pharmacokinetics and relative bioavailability of sustained-release felodipine capsule in healthy volunteers [J]. J China Pharm Univ, 2000,31:184-187.
17. Rao PR, Reddy MN, Ramakrishna S, et al. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits [J]. Eur J Pharmacol Biopharm, 2003,56:81-85.
18. Ghosh TK, Adir J, Xiang SL, et al. Transdermal delivery of metoprolol II; in vitro skin permeation and bioavailability in hairless rats [J]. J Pharm Sci, 1995, 84:158-160.